Active, Not Recruiting
Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence
NCT04797000
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
- Locations
-
- Novartis Investigative Site Narita, Chiba, Japan
- Novartis Investigative Site Kurume, Fukuoka, Japan
- Novartis Investigative Site Ohtake, Hiroshima, Japan
- Novartis Investigative Site Nishinomiya, Hyōgo, Japan